Skip to main content

Estimize Unveils Crowd-Sourced M&A Prediction Platform, Raises $1.2M Expansion Funding

leigh-drogen-estimize

Mergerize will display predictions in a bubble chart that plots potential acquisition targets─or potential acquirers─as bubbles where the size of the bubble represents the number of predictions, and where the x-axis measures predicted acquisition timeframe and the y-axis measures the average predicted deal price. Beneath this is a table that shows the number of potential buyers for a company and the average deal value, while users can also navigate to pages for specific companies and see the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Show password
Hide password

Market data costs defy cyclicality

Trading firms continue to grapple with escalating market data costs. Can innovative solutions and strategic approaches bring relief?

AI & data enablement: A looming reality or pipe dream?

Waters Wrap: The promise of AI and agents is massive, and real-world success stories are trickling out. But Anthony notes that firms still need to be hyper-focused on getting the data foundation correct before adding layers.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here